{
    "clinical_study": {
        "@rank": "147828", 
        "acronym": "4056", 
        "arm_group": [
            {
                "arm_group_label": "empirical therapy", 
                "description": "immediate initiation of antifungal therapy; Itraconazole :1-14day,iv\uff1b(400mg/day bid 1-2day, 200mg/day q.d 3-14day) 15-28day,p.o(400mg/day bid)"
            }, 
            {
                "arm_group_label": "preemptive therapy", 
                "description": "Dynamic monitoring of fungal infection,  initiation antifungal therapy when clinical diagnosis ( microbial + experiment +, G/GM, CT typical change ) approveled in two weeks Itraconazole :1-14day,iv\uff1b(400mg/day bid 1-2day, 200mg/day q.d 3-14day) 15-28day,p.o(400mg/day bid) If within two weeks without obtaining positive results, researchers determine whether initiation of antifungal therapy\u3002"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to Comparison clinical efficiency with IPFI patients who\n      treated by different protocols(empirical therapy or preemptive therapy) in ICU."
        }, 
        "brief_title": "Treatment Method Research of Invasive Pulmonary Fungal Infection", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "IFI", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases, Fungal", 
                "Mycoses"
            ]
        }, 
        "detailed_description": {
            "textblock": "a multicenter study ( a total of 2411 person-time ) found In the United States in 205,\n      antifungal therapy in empirical therapy, preemptive therapy, target therapy of respectively\n      44%, 43%, 12%. While the existing on preemptive therapy and empiric treatment comparative\n      study shows, the survival rate of the patients without differences, cost and application of\n      antifungal drugs are relatively more in empirical therapy. These findings of differences, is\n      due to the different research forecast model, treatment options vary widely, and are without\n      a prospective multicenter study of verification. Initiation of antifungal therapy time and\n      antifungal drug of choice is affected by many factors, including the risk stratification of\n      patients, clinical manifestations, bacterial infection of evidence and non interventional\n      diagnosis method results. How to grasp the opportunity to treat the fungal infections by\n      empirical therapy or preemptive therapy that has plagued the global clinical doctors. The\n      purpose of this study is aimed at the large scale prospective, multicenter study method to\n      China, severe invasive pulmonary fungal infection of the empiric treatment with preemptive\n      therapy for clinical contrast research, exploration of fungal treatment time and plan, to\n      establish China's own optimal antifungal treatment options, are reduced in patients with\n      severe fungal infection harm and increase the rate of successful treatment with\n      evidence-based medical evidence."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. More than 18 years old \uff0cmale or female\n\n          2. Expected  the time of staying in ICU longer than 72 hours and the duration of\n             mechanical ventilation for more than 48 hours\n\n          3. Pulmonary infection according to, axillary temperature\u2265 37\u2103, using broad-spectrum\n             antibiotics more than 72 hours, no better or worse\n\n          4. Candida score greater than or equal to 3\n\n          5. Child-bearing women, urine pregnancy test must be negative when screening and agreed\n             to adopt safe and effective contraceptive measures in the process\n\n          6. Male subjects must be guaranteed to use dual physical methods of contraception\n             contraceptive and sperm donation, from starting to after 30days ending treatment\n\n          7. Subjects ( or their legal representatives\uff09 have signed the informed consent\n\n        Exclusion Criteria:\n\n          1. Diagnosed with invasive fungal infection by any of the following means at the time of\n             admission 1\uff09Proved deep fungal infection by histopathology 2\uff09Peripheral blood culture\n             fungi positive at least 1 time 3\uff09Specimens from sterile sites of culture positive (\n             cerebrospinal fluid, pleural effusion and ascites\uff09\n\n          2. Renal insufficiency, creatinine clearance < 30ml/min\n\n          3. Active liver disease or suspected drug induced liver injury\n\n          4. Pregnant and lactating women\n\n          5. With imidazole or pyrrolic drug allergy or intolerance or have contraindications.\n\n          6. Not fit into the group by comprehensive judgment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "suspected Pulmonary invasive fungal Infection in ICU patients with Mechanical Ventilation"
            }
        }, 
        "enrollment": {
            "#text": "330", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01693887", 
            "org_study_id": "ITRFUN4056"
        }, 
        "intervention_browse": {
            "mesh_term": "Itraconazole"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "IFI", 
            "empirical therapy", 
            "preemptive therapy", 
            "Itraconazole"
        ], 
        "lastchanged_date": "September 25, 2012", 
        "location": [
            {
                "contact": {
                    "last_name": "di-fen wang, Director"
                }, 
                "facility": {
                    "address": {
                        "city": "Guiyang", 
                        "country": "China", 
                        "state": "Guizhou", 
                        "zip": "550004"
                    }, 
                    "name": "Affiliated Hospital of Guiyang Medical College"
                }, 
                "investigator": [
                    {
                        "last_name": "di-fen wang, Director", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "yuan-yi liu, Physician", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "xiao qi xie, physician", 
                    "phone": "86-028-85422739"
                }, 
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610041"
                    }, 
                    "name": "West China Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "yan kang, Director", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "xiao qi xie, physician", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "xiao-bo Huang, director", 
                    "phone": "86-028-87393247"
                }, 
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610071"
                    }, 
                    "name": "Sichuan provincial people's hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "xiao bo huang, director", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "yi-ping Wang, physician", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "xiao-qin zhang, physician", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "chuan zhang, Director"
                }, 
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610031"
                    }, 
                    "name": "Third people's Hospital of Chengdu City"
                }, 
                "investigator": {
                    "last_name": "chuan zhang, Director", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Comparative Study About Empirical Therapy and Preemptive Therapy to Invasive Pulmonary Fungal Infection ICU Patients in China", 
        "overall_contact": {
            "last_name": "yan kang, director", 
            "phone": "86-028-85422508"
        }, 
        "overall_contact_backup": {
            "email": "xiaoqixie@hotmail.com", 
            "last_name": "xiao qi xie, physician", 
            "phone": "86-028-85422739"
        }, 
        "overall_official": [
            {
                "affiliation": "West China Hospital", 
                "last_name": "yan kang, director", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sichuan Provincial People's Hospital", 
                "last_name": "xiao bo huang, director", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Third people's Hospital of Chengdu City", 
                "last_name": "chuan zhang, director", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Affiliated Hospital of Guiyang Medical College", 
                "last_name": "di-fen wang, director", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01693887"
        }, 
        "responsible_party": {
            "investigator_affiliation": "West China Hospital", 
            "investigator_full_name": "yan kang", 
            "investigator_title": "director\uff08ICU\uff09", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "West China Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "West China Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2011"
    }
}